Light-Scattering Spectroscopy for Detection of Breast Cancer
Status: | Recruiting |
---|---|
Conditions: | Breast Cancer, Cancer, Cancer, Cancer, Cancer, Healthy Studies |
Therapuetic Areas: | Oncology, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 5/27/2018 |
Start Date: | November 21, 2012 |
End Date: | November 21, 2020 |
Contact: | Pui Yan |
Email: | Puiyan@med.usc.edu |
Phone: | 323-865-3000 |
Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study
This pilot clinical trial studies light-scattering spectroscopy in finding disease in
patients with stage II-III breast cancer. Diagnostic procedures, such as light-scattering
spectroscopy, may help find and diagnose breast cancer
patients with stage II-III breast cancer. Diagnostic procedures, such as light-scattering
spectroscopy, may help find and diagnose breast cancer
PRIMARY OBJECTIVES: I. To evaluate whether light-scattering spectroscopy can reliably
distinguish between two subject groups: those with clinical stage II or stage III breast
cancer and those without breast cancer.
OUTLINE: Patients undergo light-scattering spectroscopy of the breast in addition to standard
of care as it relates to screening for breast cancer or treatment of breast cancer.
distinguish between two subject groups: those with clinical stage II or stage III breast
cancer and those without breast cancer.
OUTLINE: Patients undergo light-scattering spectroscopy of the breast in addition to standard
of care as it relates to screening for breast cancer or treatment of breast cancer.
Inclusion Criteria:
- Participants who are breast cancer free (mammogram "negative" within 1 month of
testing) with the absence of clinical suspicion of breast cancer on physical exam or
with clinical stage II or stage III breast cancer. PLEASE NOTE: Recruitment for this
study is only limited to patients who are scheduled for a mammogram at USC. There is
no compensation to participants.
- Provision of informed consent prior to any study-related procedures
Exclusion Criteria:
- Females with tattoos on either or both breasts
- Females with nipple piercings on either or both breasts
- Females with skin piercings (aka microdermal anchor surface or microdermal piercings)
in either or both breasts
- Females unable to provide informed consent
- Females s/p treatment for breast cancer
We found this trial at
1
site
1441 Eastlake Ave
Los Angeles, California 90033
Los Angeles, California 90033
(323) 865-3000
Principal Investigator: Jacques Van Dam
Phone: 323-865-3000
U.S.C./Norris Comprehensive Cancer Center The USC Norris Comprehensive Cancer Center, located in Los Angeles, is...
Click here to add this to my saved trials